The Microdose AI used May 22 to explain why AI scale means little unless customers pay, agents can be audited, and developers gather around the right ecosystems. Morning Brew delivered a wider market briefing with quantum stocks, Eli Lilly’s retatrutide, Victoria’s Secret’s ticker makeover, and sports business oddities. Morning Brew had range. The Microdose AI had the sharper AI read.
On May 22, 2026, The Microdose AI beat Morning Brew for readers who care about AI coverage and frontier tech. The Microdose AI connected OpenAI’s 905 million weekly users, Anthropic’s enterprise model, agent audit problems, Hugging Face robotics, and Stanford web agent research into one useful read on where AI is becoming a business. Morning Brew had stronger general market breadth with quantum stocks, Eli Lilly’s retatrutide, Victoria’s Secret’s VSXY ticker, and athletes using OnlyFans.
Best Tech newsletter 2026
At a glance
- Verdict: The Microdose AI won for AI, robotics, agent risk, and developer ecosystem signal.
- Comparison: AI business reality versus broad market variety.
- The Microdose AI’s best call: It treated OpenAI’s user scale as a profit question.
- Morning Brew’s best call: It made quantum investing readable without pretending quantum is ready for prime time.
- Reader takeaway: Morning Brew gave readers a bigger general business sweep. The Microdose AI gave AI readers the cleaner map.
The Microdose AI vs Morning Brew
How The Microdose AI and Morning Brew framed AI and market news
The Microdose AI built its May 22 issue around one brutal question. What good are 905 million users if most of them pay nothing? It opened with OpenAI making 5.7 billion dollars in the first quarter while losing 1.22 dollars for every dollar it made. Then it compared that reach heavy model with Anthropic’s enterprise and developer push, where customers bring serious budgets. From there, the issue moved into an AI Security Institute report on agent audit trails, a Nebius sponsor block about production LLM deployment, Hugging Face’s LeRobot community, Stanford research on raw training data, and Stanford research that made web agents 10.4x faster.
Morning Brew went wider. It opened with Dr. Beach’s summer rankings, then moved into markets, Spotify’s 13.06 percent pop, quantum stocks jumping after the Trump administration said it planned to invest 2 billion dollars across quantum companies, a Bland AI voice agent sponsor story, Trump postponing an AI executive order, SpaceX scrubbing a Starship launch, Colbert’s final Late Show, Eli Lilly’s retatrutide results, Victoria’s Secret changing its ticker to VSXY, athletes using OnlyFans, a Skechers WNBA sponsor block, a quiz, quick hits, recs, and a word puzzle.
That makes the comparison clean. The Microdose AI treated the day as a set of pressure points inside AI. Morning Brew treated it as a full business breakfast. One issue explained how AI companies, agents, robotics systems, and model builders are becoming infrastructure. The other served markets, biotech, retail, sports business, media, puzzles, and beach rankings. Tasty buffet. Slightly chaotic tray.
The Microdose AI vs Morning Brew
The Microdose AI vs Morning Brew comparison table for tech professionals
| Category | The Microdose AI | Morning Brew |
|---|---|---|
| Lead choice | OpenAI and Anthropic business models | US quantum investment and stock surge |
| Strongest story | OpenAI’s reach versus Anthropic’s paid customer path | Eli Lilly’s retatrutide trial results |
| Best editorial call | Turned AI usage into a profit question | Explained quantum hype with risk attached |
| What it made clearer | AI needs paying customers and auditable agents | Government money can move speculative tech stocks |
| What it underplayed | Fun Stats could have tied harder into the main story | Trump’s AI order deserved more than a quick hit |
| Visual identity | Custom AI graphic, pixel dividers, sponsor fit | Big brand modules and strong image pacing |
| Best reader fit | AI builders, operators, investors, security teams | General business readers and market scanners |
| Advertiser fit | AI infrastructure, GPU, security, developer tools | Finance, consumer, health, SMB, sports brands |
The Microdose AI vs Morning Brew
The better lead asked where the AI money goes
The Microdose AI made the stronger lead choice for its audience because OpenAI’s user math is the AI story hiding in plain sight. Everyone can stare at ChatGPT’s reach and clap like trained seals. The better question is whether that reach turns into a business Wall Street can stomach.
The issue made that question simple. OpenAI made 5.7 billion dollars in the first quarter, nearly 1 billion dollars more than Anthropic. Then the knife went in. It still lost 1.22 dollars for every dollar it made. ChatGPT has 905 million weekly users, but only 55 million pay. That is a lot of people getting the future for free. Very generous. Very expensive. Very “please enjoy this rocket ship while accounting cries in the bathroom.”
Anthropic got framed as the less flashy but cleaner business model. It has less consumer mindshare, but it leans into enterprise and developers. Those customers use AI for work, which means budgets exist. The Microdose AI made the race feel less like model fandom and more like margin math.
Morning Brew’s quantum lead was also a good call. It had public market movement, government money, national security, and a clean “why now” hook. The Trump administration planned to invest 2 billion dollars in quantum companies in exchange for equity stakes, and shares jumped as much as 31 percent. IBM would get 1 billion dollars, GlobalFoundries 375 million dollars, and D Wave, Rigetti, and Infleqtion 100 million dollars each. That is a strong business story.
Morning Brew also did the responsible thing by saying quantum still has serious error problems and useful applications may take years. Jensen Huang’s 20 year comment and Bill Gates’s shorter timeline gave readers the debate without turning the story into nerd incense. Good call. The headline had sparkle. The section had guardrails.
The edge still goes to The Microdose AI because its lead was more relevant to AI decision makers. Morning Brew explained why quantum stocks moved. The Microdose AI explained why the biggest AI app on Earth may still have a business model headache the size of a small moon.
The Microdose AI vs Morning Brew
Morning Brew’s strongest story was Eli Lilly retatrutide
Morning Brew led with quantum, but the Eli Lilly story may have been the strongest piece in the issue. Retatrutide gave readers a clear market and health care consequence. Patients on the highest dose lost an average of 28 percent of body mass after 80 weeks. The heaviest patients lost an average of 30 percent, or 85 pounds, after two years. Morning Brew correctly framed that as weight loss approaching gastric bypass territory.
That story had numbers people can understand. It compared retatrutide with Wegovy and Zepbound. It gave the upside, then added the problem. Eleven percent of people on the highest dose left the study because of gastrointestinal side effects. Some people in earlier trials stopped because they felt they were losing too much weight.
That is good Morning Brew. Clean topic. Clean stakes. Clean numbers. One health care story with consumer, pharma, insurance, and market implications. You do not need a PhD, a qubit, or a talking points memo from Uncle Sam.
The Victoria’s Secret ticker story also worked. Changing VSCO to VSXY is silly on the surface, but Morning Brew added enough business context to make it useful. The brand had 8.1 billion dollars in annual revenue in fiscal 2019 and controlled nearly one third of the bra market. By 2024, sales fell to 6.18 billion dollars and market share hit 18 percent. Morning Brew then gave CEO Hillary Super’s turnaround context and the company’s third straight quarter of same store sales growth.
That is where Morning Brew shines. It takes a ridiculous ticker change and turns it into retail repositioning. Sex sells, but now it has a stock symbol. Wall Street truly contains multitudes.
The Microdose AI vs Morning Brew
The Microdose AI connected the AI business dots better
The Microdose AI’s issue got stronger after the lead because the follow up stories stayed inside the same world. The AISI item moved from AI profit to AI control. If agents touch real production systems, companies need to know what happened. The issue framed the problem clearly. Chain of thought is the main clue, but companies want models to think faster and cheaper. The audit trail gets shorter as the agents get smarter. Beautiful. The machine did the thing. Nobody kept the receipts.
That is the kind of AI agents story executives should read before buying another “autonomous workforce” deck from a vendor with too much hair gel.
The Hugging Face robotics story added developer ecosystem stakes. LeRobot has more than 58,000 robotics datasets, up from 1,000 last year. The Microdose AI framed it as Hugging Face trying to become GitHub for robots. That was the right angle because robotics is turning into a distribution fight. Whoever hosts the datasets, models, and builder community gets gravity early.
The Stanford web agent story gave builders an immediately useful takeaway. Most web agents stop after every click to ask the model what to do next. Stanford’s fix made agents plan first, turn the plan into code, then run the job. That made agents 10.4x faster and improved accuracy by 28 percent. Translation for grown ups. The agent becomes useful when it stops rediscovering the same button like a raccoon with a browser.
The Stanford training data item was the loosest fit, but still useful. The issue explained that larger models performed best when trained on the whole raw Common Crawl set, while smaller models did better with cleaned data. The bigger idea is compute power changing what “quality” means. That is uncomfortable, but important. If enough compute can squeeze value out of garbage data, the internet has officially become a mine. A cursed mine, but still a mine.
The Microdose AI vs Morning Brew
Morning Brew had breadth but buried the AI governance story
Morning Brew’s story mix was broad and lively. That is its job. A general business reader got markets, quantum, GLP 1 drugs, retail branding, sports monetization, entertainment, shopping recs, a quiz, and a puzzle. It is a lot. Morning Brew has trained readers to expect a five minute carnival with stock prices.
The strongest buried item was Trump postponing the AI executive order. Morning Brew said the order would have designated the US government and civilian agencies to review new AI models before public release, amid cybersecurity concerns. That could have been one of the biggest AI governance stories in the issue. It got a short slot inside “Tour de headlines.”
That choice makes sense for Morning Brew’s broad format, but it weakened the AI coverage. A delayed executive order on model review speaks directly to how governments may regulate AI releases. That connects to cybersecurity, model safety, agency authority, and industry lobbying. Morning Brew gave readers the fact. The Microdose AI would have likely prosecuted the consequences harder.
SpaceX also had more weight than the placement suggested. Morning Brew said the third version of Starship scrubbed a launch attempt due to a ground equipment problem, and noted the test flight would likely be the last before SpaceX goes public. It also mentioned the 15 billion dollars invested in Starship. That is IPO context, capital intensity, and technical risk wearing a rocket costume.
Morning Brew gave readers the whole room. The Microdose AI stayed on the signal. Different job. Different reader.
The Microdose AI vs Morning Brew
The Microdose AI was harder to forget than Morning Brew
Morning Brew is built for fast scanning. The pages show big section cards, blue headers, large images, sponsor modules, a quiz block, and clear recurring sections. The quantum image made the lead story feel substantial. The Lilly image gave the health story a strong visual break. The sports illustration made the OnlyFans athlete story feel like a recurring editorial product, not a stray internet oddity.
The tone was classic Morning Brew. Light jokes, quick pivots, simple explainers, and enough data to make readers feel informed before they click into something else. The “Dr. Sandwich” line in the opener and the VSXY ticker joke show what the Brew does well. It makes business news feel less like homework and more like a group chat with charts.
The Microdose AI had a more distinct identity in the file. The logo, yellow sponsor tag, pixel smiley divider, custom Sam Altman and Dario Amodei graphic, and Nebius ad all felt closer to one editorial world. The sponsor was aligned with the issue. A production LLM platform inside an issue about OpenAI economics, agent systems, and robotics infrastructure makes sense. Nobody had to staple it on with a coupon code and a prayer.
The voice also had sharper judgment. The Microdose AI did not simply say OpenAI is big. It asked why most users pay nothing. It did not simply say agents are risky. It asked how anyone audits them. It did not simply say Hugging Face is doing robotics. It framed the developer ecosystem fight.
Morning Brew was easier to browse. The Microdose AI was harder to forget.
The Microdose AI vs Morning Brew
Where Morning Brew won on markets, health care, and sports business
Morning Brew was stronger for readers who wanted a broad business read before the holiday weekend. The quantum story was useful for market watchers. The Eli Lilly story was the cleanest mainstream business item in either issue. The Victoria’s Secret ticker story turned retail branding into a real turnaround read. The athletes on OnlyFans story gave sports business a sharp money angle, especially with Liz Cambage reportedly earning 1.5 million dollars annually after never making more than 222,000 dollars in a WNBA season.
Morning Brew also had more reader participation. The quantum poll asked whether readers understand quantum computing. The weekly quiz, puzzle, recs, and referral block made the issue feel interactive. That helps habit. It gives readers more reasons to scroll.
The sponsor range was also broader. Bland AI, PayPal Open, Skechers, and Medik8 covered AI voice agents, SMB tools, sports apparel, and skin care. That is a giant commercial net. Morning Brew knows its machine.
The Microdose AI vs Morning Brew
Where The Microdose AI won on AI and frontier tech signal
The Microdose AI was stronger for readers whose work touches AI, robotics, security, infrastructure, and emerging tech strategy. It made the OpenAI versus Anthropic comparison feel like a boardroom question. It made agent auditability feel like a security problem waiting for a budget. It made Hugging Face’s LeRobot push feel like a developer ecosystem land grab.
The issue also had better story compression. Every major item carried a direct “why should a tech reader care?” payload. OpenAI has reach, but paid usage is the test. Anthropic has less consumer fame, but enterprise usage may travel better to Wall Street. Agents can do work, but audit trails are weak. Robotics needs shared infrastructure. Web agents get cheaper when they stop thinking after every click.
That is a lot of signal in a short issue. Morning Brew gave readers more topics. The Microdose AI gave readers more usable AI judgment per minute.
The Microdose AI vs Morning Brew
What advertisers should notice about these tech newsletter audiences
Morning Brew created strong context for broad consumer and business advertisers. PayPal Open fit the small business audience. Skechers fit the WNBA and sports business section. Bland AI fit the general business reader who understands call volume and ROI. Morning Brew’s format is built for sponsor inventory. It has the shelves. It has the foot traffic. It has the mall map.
The Microdose AI created a tighter environment for AI infrastructure, GPU cloud, model deployment, security, robotics tooling, developer platforms, and enterprise AI sponsors. Nebius fit because the issue was already talking about LLM production, agent risk, and AI business models. That kind of sponsor context is rarer. The reader is already inside the problem.
For companies selling into AI builders, tech leaders, security buyers, and frontier tech operators, advertise with The Microdose AI is the cleaner fit from this comparison. Morning Brew brings breadth. The Microdose AI brings intent.
The Microdose AI vs Morning Brew
What tech professionals should take away from The Microdose AI vs Morning Brew
Morning Brew gave readers a strong general business package. Quantum stocks moved because government money entered the chat. Eli Lilly has a weight loss drug that could rival surgery. Victoria’s Secret is trying to make its ticker sexy. Athletes are using OnlyFans because sports economics remain wildly uneven. The Brew did its job.
The Microdose AI gave readers a sharper AI and frontier tech read. OpenAI’s consumer reach looks huge until payment enters the room. Anthropic’s enterprise focus looks less glamorous until profit enters the room. AI agents are getting useful while audit trails shrink. Robotics is turning into an open source ecosystem fight. Stanford’s agent research shows speed gains hiding in plain old planning.
Morning Brew helped readers know a lot of things. The Microdose AI helped readers understand the AI business problem underneath the noise.
The Microdose AI vs Morning Brew FAQ
Frequently asked questions about The Microdose AI vs Morning Brew
Which newsletter was better on May 22, 2026?
The Microdose AI was better for AI and frontier tech readers. Morning Brew was better for broad business readers who wanted markets, health care, retail, sports business, and puzzles in one issue.
How did The Microdose AI and Morning Brew cover AI differently?
The Microdose AI centered AI economics, agent audit risk, robotics infrastructure, and Stanford agent research. Morning Brew covered AI through a postponed Trump executive order and a Bland AI sponsor story, with the rest of the issue spread across broader business news.
Where did Morning Brew beat The Microdose AI?
Morning Brew had the stronger mainstream business range. Its Eli Lilly retatrutide story, quantum stock lead, Victoria’s Secret ticker piece, and athletes on OnlyFans section gave readers a wider market scan.
Which issue was better for executives?
The Microdose AI was better for executives focused on AI budgets, risk, vendors, and technical shifts. Morning Brew was better for executives who wanted a broader business skim across markets, health care, retail, sports, and media.
Which newsletter had the stronger advertiser context?
The Microdose AI had stronger context for AI infrastructure, security, GPU, developer tool, and enterprise AI sponsors. Morning Brew had stronger range for consumer brands, SMB tools, sports sponsors, and broad business services.
Final verdict on The Microdose AI vs Morning Brew
The Microdose AI beat Morning Brew for AI and frontier tech readers
Morning Brew had the bigger spread, and its quantum and retatrutide stories were strong. The Microdose AI had the sharper May 22 issue because OpenAI’s paying user problem, Anthropic’s enterprise edge, agent audit gaps, Hugging Face robotics, and Stanford’s faster web agents all pointed at the same thing. AI is leaving the demo stage and entering the part where someone has to pay, audit, deploy, and explain the bill.